Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02559401 · ClinicalTrials.gov registry record
Validation of Edema-invariant Multi-shell High Angular Resolution Diffusion Imaging (msHARDI)-Based Tractography With Intra-operative Cortical Stimulation
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 68
- Enrollment target
NCT02559401 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 68 participants.
The verdict
NCT02559401 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 68 participants
- Enrollment target
Study Summary
Currently, standard-of-care tractography is based on information obtained from diffusion tensor imaging (DTI). DTI is a diffusion magnetic resonance imaging (dMRI) technique that is routinely obtained on neurosurgical patients to assist in pre-operative planning. The primary objective of the proposed study is to determine the ability of msHARDI-based tractography to discern fibers in edematous brain regions.
Interventions
- OTHER MRI
- OTHER Neurocognitive battery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2014-06 |
| Est. Completion | 2022-07-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02559401
The ClinicalTrials.gov registry entry for NCT02559401 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.
NCT02559401 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02559401 about?
NCT02559401 is a clinical study titled "Validation of Edema-invariant Multi-shell High Angular Resolution Diffusion Imaging (msHARDI)-Based Tractography With Intra-operative Cortical Stimulation". Currently, standard-of-care tractography is based on information obtained from diffusion tensor imaging (DTI). DTI is a diffusion magnetic resonance imaging (dMRI) technique that is routinely obtained on neurosurgical patients to assist in pre-operative planning. The primary objective of the propose...
What is the current status of trial NCT02559401?
This trial is currently completed. The enrollment target is 68 participants. The study started on 2014-06. Estimated completion is 2022-07-07.
What interventions are being tested in trial NCT02559401?
The interventions under investigation include: MRI (OTHER), Neurocognitive battery (OTHER).
Who is sponsoring clinical trial NCT02559401?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.